Delays out of CHM's control, the whole sector is affected, no blame on CHM. The bright side is the low sp. Those who are patient will make a fortune here over the coming years, financial foundation is built now, not when sp hits the $ range.
Great to see there is progress, let's hope for first patient dosed soon. Soon the worldwide CD19 success story will add the CD17-CDH17 success story to it.
GLTA
Ann: Completion of Viral Vector Manufacturing for Phase 1 trial, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 243067 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14771167 | 22 |
View Market Depth
| Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |